Back
Sangamo Therapeutics Stock Price Chart
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.
Sell
29
SGMO
Sangamo Therapeutics
Last Price:
0.55
Seasonality Move:
-2.28%
7 Day Trial
ALL ACCESS PASS
$
7
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.- The current trend is relatively stagnant and SGMO is experiencing selling pressure, which indicates risk of future bearish movement.
Sangamo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.52 | Buy |
| 20-day SMA: | 0.53 | Sell |
| 50-day SMA: | 0.73 | Sell |
| 200-day SMA: | 0.69 | Sell |
| 8-day EMA: | 0.52 | Sell |
| 20-day EMA: | 0.55 | Sell |
| 50-day EMA: | 0.62 | Sell |
| 200-day EMA: | 0.91 | Sell |
Sangamo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 42.31 | Sell |
| Chaikin Money Flow: | -556565 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.5 - 0.58) | Sell |
| Bollinger Bands (100): | (0.41 - 0.87) | Sell |
Sangamo Therapeutics Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sangamo Therapeutics Stock
Is Sangamo Therapeutics Stock a Buy?
- Sangamo Therapeutics share price is 0.52 while SGMO 8-day simple moving average is 0.52, which is a Buy signal.
- The stock price of SGMO is 0.52 while Sangamo Therapeutics 20-day SMA is 0.53, which makes it a Sell.
- Sangamo Therapeutics 50-day simple moving average is 0.73 while SGMO share price is 0.52, making it a Sell technically.
- SGMO stock price is 0.52 and Sangamo Therapeutics 200-day simple moving average is 0.69, creating a Sell signal.
SGMO Technical Analysis vs Fundamental Analysis
Sell
29
Sangamo Therapeutics (SGMO)
is a Sell
Is Sangamo Therapeutics a Buy or a Sell?
-
Sangamo Therapeutics stock is rated a Sell
The current Sangamo Therapeutics [SGMO] share price is $0.52. The Score for SGMO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Sangamo Therapeutics Stock Info
Market Cap:
93.39M
Price in USD:
0.52
Share Volume:
746.61K
Sangamo Therapeutics 52-Week Range
52-Week High:
1.67
52-Week Low:
0.29
Sell
29
Sangamo Therapeutics (SGMO)
is a Sell
Sangamo Therapeutics Share Price Forecast
-
What is the Sangamo Therapeutics stock price today?
The Sangamo Therapeutics stock price is 0.52 USD today. -
Will SGMO stock go up or go down?
Sangamo Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sangamo Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sangamo Therapeutics is overvalued.
Is Sangamo Therapeutics Stock a Buy?
- Sangamo Therapeutics share price is 0.52 while SGMO 8-day exponential moving average is 0.52, which is a Sell signal.
- The stock price of SGMO is 0.52 while Sangamo Therapeutics 20-day EMA is 0.55, which makes it a Sell.
- Sangamo Therapeutics 50-day exponential moving average is 0.62 while SGMO share price is 0.52, making it a Sell technically.
- SGMO stock price is 0.52 and Sangamo Therapeutics 200-day simple moving average is 0.91, creating a Sell signal.
Fundamental Analysis of Sangamo Therapeutics
Is Sangamo Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $0.53 per share.
Technical Analysis of Sangamo Therapeutics
Should I short Sangamo Therapeutics stock?
- SGMO Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Sangamo Therapeutics is a Sell
- Sangamo Therapeutics Relative Strength Index (RSI) is 42.31, which suggest Sangamo Therapeutics is oversold
- The Bollinger Bands (25) for Sangamo Therapeutics is (0.5 - 0.58), which suggest Sangamo Therapeutics is a Sell
- The Bollinger Bands (100) for Sangamo Therapeutics is (0.41 - 0.87), which suggest Sangamo Therapeutics is a Sell
* Sangamo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.